Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.17M Buy
9,125
+155
+2% +$18.1K 0.52% 38
2026
Q1
$1.08M Sell
8,970
-297
-3% -$34.3K 0.59% 39
2025
Q4
$975K Buy
+9,267
New +$870K 0.47% 42
2024
Q4
$1.15M Sell
11,570
-510
-4% -$52.6K 0.74% 31
2024
Q3
$1.37M Buy
12,080
+247
+2% +$29.3K 1.12% 25
2024
Q2
$1.46M Sell
11,833
-251
-2% -$32.3K 1.01% 33
2024
Q1
$1.59M Buy
+12,084
New +$1.49M 1.45% 17

Other funds holding MRK

Oxford Wealth Group's MRK Position: Q2 2026 in Review

Oxford Wealth Group increased its Merck (MRK) stake by 1.7% in Q2 2026, buying an estimated $18.1K and bringing the position to 9,125 shares worth $1.17M. The position accounts for 0.52% of the portfolio, ranked #38.

Oxford Wealth Group first reported a position in MRK in Q1 2024 and has held it in 7 quarters since. The position peaked at $1.59M in Q1 2024. 3,850 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Oxford Wealth Group held 9,125 shares of Merck worth $1.17M as of Q2 2026.
  • Oxford Wealth Group bought 155 Merck shares in Q2 2026, an estimated $18.1K.
  • Merck made up 0.52% of Oxford Wealth Group's portfolio in Q2 2026, its #38 holding.
  • Oxford Wealth Group first reported a position in Merck in Q1 2024 and has held it in 7 quarters since.
  • Oxford Wealth Group's Merck position peaked at $1.59M in Q1 2024.
  • 3,850 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Oxford Wealth Group's 13F filing for Q2 2026, filed 13 Aug 2026.